Paion UK Ltd.
16
0
1
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.3%
1 terminated/withdrawn out of 16 trials
93.3%
+6.8% vs industry average
38%
6 trials in Phase 3/4
36%
5 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Role: collaborator
Assessment of the Pharmacodynamic and Pharmacokinetic Interaction of Remimazolam and Remifentanil
Role: lead
Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery
Role: lead
An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours
Role: lead
REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study
Role: collaborator
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Role: lead
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
Role: lead
Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery
Role: lead
A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
Role: lead
Remimazolam Phase II Cardiac Anesthesia Study
Role: lead
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
Role: lead
Absolute Oral Bioavailability of Remimazolam
Role: lead
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users
Role: lead
A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability
Role: lead
Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy
Role: lead
Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy
Role: lead
All 16 trials loaded